Valuation vs Own History COMMODITY
— slow-moving; 60d lag; EV/EBITDA canonical
Research notes (read before interpreting):- The news-vs-expectations thesis is UNTESTED by the backtest (look-ahead-impossible). Only Agent 6 live forward-tracking can validate whether news_adj improves outcomes. Treat news as a bounded refinement on trial, not a proven driver.
- Fundamentals are annual with a 60-day reporting lag; EV/EBITDA is the valuation metric (P/E broke on 45 loss-year rows). Valuation reads are slow-moving, not point-in-time precise.
Percentile within this ticker's own 6-year fundamental history. High = expensive vs itself.
| FY | EV/EBITDA | P/E | P/S | Revenue | EPS |
| 2026 |
15.44x |
25.46x |
8.29x |
$8.2B |
$3.10 |
| 2025 |
155.12x |
neg |
16.94x |
$5.8B |
$-1.02 |
| 2024 |
72.60x |
neg |
10.59x |
$5.5B |
$-1.08 |
| 2023 |
24.61x |
neg |
6.21x |
$5.9B |
$-0.19 |
| 2022 |
67.70x |
neg |
12.75x |
$4.5B |
$-0.53 |
Earnings Surprise Track Record COMMODITY
Canonical signal: avoid-misses is the durable edge (misses lag the basket ~4%/21d excess); beats merely match the sector once drift is stripped. Regime-dependent, effectively small-sample — not proven.
| Date | EPS act | EPS est | EPS surp% |
Rev surp% | Excess/21d |
| 2026-05-27 |
$0.80 |
$0.80 |
+0.3% |
+0.5% |
n/a |
| 2026-03-05 |
$0.80 |
$0.79 |
+1.0% |
+0.5% |
+15.0% |
| 2025-12-02 |
$0.76 |
$0.74 |
+2.3% |
+0.3% |
-12.0% |
| 2025-08-28 |
$0.67 |
$0.67 |
-0.4% |
-0.2% |
+16.3% |
| 2025-05-29 |
$0.62 |
$0.61 |
+1.3% |
+1.0% |
+11.7% |
| 2025-03-05 |
$0.60 |
$0.59 |
+1.7% |
+1.0% |
-13.0% |
| 2024-12-03 |
$0.43 |
$0.41 |
+4.9% |
+4.1% |
-1.0% |
| 2024-08-29 |
$0.30 |
$0.29 |
+2.2% |
+1.9% |
-14.0% |
| 2024-05-30 |
$0.24 |
$0.24 |
+1.2% |
+0.6% |
-3.5% |
| 2024-03-07 |
$0.46 |
$0.46 |
-0.4% |
+0.4% |
-4.8% |
| 2023-11-30 |
$0.41 |
$0.40 |
+2.5% |
+1.3% |
+4.8% |
| 2023-08-24 |
$0.33 |
$0.32 |
+3.1% |
-4.3% |
-0.7% |
| 2023-05-25 |
$0.31 |
$0.29 |
+6.9% |
+1.6% |
-12.3% |
| 2023-03-02 |
$0.46 |
$0.46 |
+0.0% |
+1.3% |
-8.1% |
| 2022-12-01 |
$0.57 |
$0.59 |
-3.4% |
-1.1% |
-11.4% |
| 2022-08-25 |
$0.57 |
$0.56 |
+1.8% |
-0.0% |
+2.0% |
| 2022-05-26 |
$0.52 |
$0.51 |
+2.0% |
+1.4% |
-13.9% |
| 2022-03-03 |
$0.50 |
$0.48 |
+4.2% |
+1.5% |
+9.2% |
| 2021-12-02 |
$0.43 |
$0.38 |
+13.2% |
-7.3% |
-1.3% |
| 2021-08-26 |
$0.34 |
$0.31 |
+9.7% |
-6.2% |
+3.5% |
Post-Earnings Revisions COMMODITY
— how consensus moved after each print
No computed revisions yet — snapshots need to bracket a print.
Consensus EPS Revision Trajectory COMMODITY
Forward-year consensus EPS over time — shows how estimates move after each print. Data accrues forward from snapshot start date.
News Lean UNPROVEN LIVE
— UNPROVEN LIVE-ONLY: no historical validation possible
▲ bullish
long
2026-07-23
NVDA $2B strategic investment was beyond analyst modeling; validates MRVL as #2 in custom silicon behind AVGO — consensus had underweighted MRVL ASIC TAM; KeyBanc jumped to $400 PT.
source ↗
▼ bearish
near
2026-07-21
Strong 63.3% revenue growth and Teralynx product news could not offset macro fear that hyperscaler AI capex may moderate — market re-rated the sector and MRVL got caught in the selloff despite solid fundamentals
source ↗
▲ bullish
long
2026-07-14
Upgrades reflect higher custom silicon conviction from Tier-1 hyperscalers with backlog now stretching to 2030; consensus was anchored on shorter cycle, so these revisions structurally lift estimates.
source ↗
▲ bullish
long
2026-06-24
Triple catalyst: Nvidia CEO endorsement as next trillion-dollar co, S&P 500 forced buying on June 22, and Q1 FY2027 call raised interconnect revenue growth guide from 50% to 70% — all three beat analyst expectations simultaneously; BofA raised PT to $365 from $240.
source ↗
▼ bearish
near
2026-06-23
Inclusion was well-telegraphed; passive forced buying already priced in by the time of the event; CFO insider selling adds near-term overhang despite strong Q1 beat ($2.42B) and Q2 guide $2.7B (+3% above estimates)
source ↗
Analyst Context — the consensus we're trying to beat
Consensus PT
$251.21
+44.0% from current
Price targets from FMP consensus. Not a recommendation.